- Home
- WSBF vs STRO Comparison
WSBF vs STRO Comparison
Compare WSBF & STRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | WSBF | STRO |
|---|---|---|
| Founded | 1921 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Savings Institutions | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 288.1M | 94.9M |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | WSBF | STRO |
|---|---|---|
| Price | $16.68 | $9.92 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $19.67 |
| AVG Volume (30 Days) | 38.6K | ★ 112.9K |
| Earning Date | 01-27-2026 | 11-06-2025 |
| Dividend Yield | ★ 3.49% | N/A |
| EPS Growth | ★ 87.32 | N/A |
| EPS | ★ 1.32 | N/A |
| Revenue | ★ $137,060,000.00 | $105,646,000.00 |
| Revenue This Year | N/A | $62.61 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $12.98 | ★ N/A |
| Revenue Growth | ★ 2.87 | N/A |
| 52 Week Low | $11.61 | $5.23 |
| 52 Week High | $17.24 | $21.50 |
Technical Indicators
Market Signals| Indicator | WSBF | STRO |
|---|---|---|
| Relative Strength Index (RSI) | 57.00 | 78.91 |
| Support Level | $16.87 | $9.53 |
| Resistance Level | $16.27 | $10.10 |
| Average True Range (ATR) | 0.35 | 0.93 |
| MACD | 0.04 | 0.15 |
| Stochastic Oscillator | 56.28 | 98.52 |
Price Performance
Historical ComparisonAbout WSBF Waterstone Financial Inc. (MD)
Waterstone Financial Inc is a holding company. Through its subsidiaries, it operates in two reportable segments: Community Banking and Mortgage Banking. The Community Banking segment provides consumer and business banking products and services to customers, which include various types of loans, deposits, and personal investment services. The Mortgage Banking segment involves residential mortgage loans for the primary purpose of sale in the secondary market. The vast majority of its revenue comes from the Community Banking segment.
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.